Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/medicine-technology-1/thomson-reuters-clinical-surveillance-solution-offers-powerful-new-functionality-to-improve-clinical-quality-and-reduce-costs-6083-3/;msg90356) was not found.

Search medicine technology 1 thomson reuters clinical surveillance solution offers powerful new functionality to improve clinical quality and reduce costs 6083 3 ;msg90356 at Google

Search medicine technology 1 thomson reuters clinical surveillance solution offers powerful new functionality to improve clinical quality and reduce costs 6083 3 ;msg90356 at Yahoo

Search medicine technology 1 thomson reuters clinical surveillance solution offers powerful new functionality to improve clinical quality and reduce costs 6083 3 ;msg90356 at Msn

Google
 
(Date:11/26/2009)...ylococcus Aureus ) and other drug-resistant bacter...ma prototype devices have been developed to offer ...ails. , Two prototype devices have been develope...(e.g. hands and feet) in hospitals and public spac...other to shoot bacteria-killing agents into infest...
(Date:11/25/2009)... stomach, may be used to boost resistance to, or s...School of Medicine researchers report in a study p...oscience . , Parkinson,s disease is caused by a ... midbrain known as the substantia nigra, which is ...uction of dopamine in late-stage Parkinson,s cause...
(Date:11/25/2009)...ice officers and ambulance workers faced a terrify...x. They battled to save people from the collapsing...s and evacuated as many people as they could in an...And making their jobs even harder was the problem ...ir relatives jammed mobile networks with calls and...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Hormone ghrelin can boost resistance to Parkinson's disease 2Magic box for mission impossible 2Magic box for mission impossible 3Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2009 Earnings Release Date and Teleconference 53155 1Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2009 Earnings Release Date and Teleconference 53155 2Study Finds Weight Loss Surgery Safer Than Thought 53152 1Study Finds Weight Loss Surgery Safer Than Thought 53152 2Study Finds Weight Loss Surgery Safer Than Thought 53152 3Express Scripts Reports Strong Second Quarter Earnings 53148 1Express Scripts Reports Strong Second Quarter Earnings 53148 2Express Scripts Reports Strong Second Quarter Earnings 53148 3Express Scripts Reports Strong Second Quarter Earnings 53148 4Express Scripts Reports Strong Second Quarter Earnings 53148 5Express Scripts Reports Strong Second Quarter Earnings 53148 6Express Scripts Reports Strong Second Quarter Earnings 53148 7Express Scripts Reports Strong Second Quarter Earnings 53148 8Express Scripts Reports Strong Second Quarter Earnings 53148 9Express Scripts Reports Strong Second Quarter Earnings 53148 10Express Scripts Reports Strong Second Quarter Earnings 53148 11Express Scripts Reports Strong Second Quarter Earnings 53148 12Express Scripts Reports Strong Second Quarter Earnings 53148 13Express Scripts Reports Strong Second Quarter Earnings 53148 14
(Date:11/30/2009)...and dessert at the holiday table are even less of ...According to a new research report recently appear...ebj.org ), a diet that is high in fat and in sugar...our bodies to store too much fat. This means these... difficult task of converting high-fat and high-su...
(Date:11/30/2009)...J. Rappa, MD, explores the intricate connection be...Healing Heart to Soul: One Doctor’s Journey ...09). , Dallas, TX (Vocus)...o let go of negative emotions, whether caused by u...houlders. Oftentimes, this disease of the human sp...
(Date:11/30/2009)...ov. 30 EMD Serono, an affiliate of...hat it received a refuse to file letter from the U...ug Application (NDA) for Cladribine Tablets, EMD S...on of cladribine, as a therapy for relapsing forms...ill work closely with the FDA to fully understand ...
(Date:11/30/2009)...y help delay progression and reduce expenses, rese...ay News) -- Medical care for osteoarthritis patien...r, according to a new study. , Of that amount, ....1 billion in out-of-pocket costs. Annual insurer ... male patient. Women also have higher out-of-pocke...
(Date:11/30/2009)...ting a tumor without disturbing normal tissue pres...apies can be invasive and harsh. , Researchers a...y they might deliver the right therapy directly to...which specifically bind to living tumor tissue. ,...nt with liver cancer until they found the best mol...
Breaking Medicine News(10 mins):Health News:Western diets turn on fat genes 2Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 2Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 3Health News:Osteoarthritis Costs U.S. Over $185 Billion a Year 2Health News:First live targeting of tumors with RNA-based technology 2Health News:First live targeting of tumors with RNA-based technology 3
NK Cell Chip-IHC from 3H Biomedical AB
UCB PDC Cell Chip-IHC from 3H Biomedical AB
Guanosine 5′-O-(2-Thiodiphosphate), Trilithium Salt from Calbiochem
Suramin, Sodium Salt from Calbiochem
Biology Products:
Hardy Micro Dissector
Hardy Nasal Bivalve Specula
Landolt Hypophysectomie Instrument, Spoon
Hardy Pituitary Spoons
Medicine Products:
(Date:11/25/2009)..., Ambassador to Speak at ... Toronto, Canada (Vocus) November 25, 2009 -- Amba..., ,Who: ,David Appia, French Ambassador for Intern...vest in France Agency ,To view a biography of Davi...: ,Ambassador Appia is available to meet with pres...
(Date:11/25/2009)..., , BEIJING, Nov. 25 /PRNewswi... developer and provider of vaccines, announced tod... to establish Sinovac (Dalian) Vaccine,Technology ...develop, produce,and commercialize human-use vacci...erience in developing and commercializing world-cl...
(Date:11/24/2009)..., This release is available in German . ,...cation cards: RFID tags (Radio Frequency Identific...ryday life. They make it possible to label objects... frequency. The appropriate scanner can read and p...ls can be affixed to goods under production condit...
(Date:11/24/2009)..., The New York investment...Ltd (ASX:NEU) has agreed an AU$6.7 mil convertible...investor. The private placement was arranged by KT...d advisor. , New York (PR... investment bank KTA Capital, LLC ("KTA Capit...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
(Date:11/30/2009)...N.J. and CHICAGO, Nov. 30 Today at...f the Radiological Society of North America (RSN...d the enrollment of the first patient in an intern...fficacy and safety of florbetaben (BAY 94-9172) PE... in the brain, which are a pathological hallmark o...
(Date:11/30/2009)...TEL AVIV, Israel, November 30 Opto...III(TM) dual channel microphone, the most advanced...l magnetic resonance imaging,(fMRI) environments. ... major step forward for fiber,optic microphone tec...r, with,low-latency adaptive noise cancelling. The...
(Date:11/30/2009)... INDIANAPOLIS, Nov. 30 T...roved Cymbalta® (duloxetine HCl) for the main...(GAD) in adults, Eli Lilly and Company (NYSE: LL...ety disorder can be a chronic illness, it is impor...ent option that is effective in both the acute and...
Breaking Medicine Technology:Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 1NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 2NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 3Roxane Laboratories Inc Announces the Launch of Risperidone Oral Solution 1mg mL 53140 1Roxane Laboratories Inc Announces the Launch of Risperidone Oral Solution 1mg mL 53140 2Osteotech Resumes Shipments of Bulgarian Tissue 13259 1Osteotech Resumes Shipments of Bulgarian Tissue 13259 2Osteotech Resumes Shipments of Bulgarian Tissue 13259 3